Company Profile (AI Text)
Name: Smartweave, Inc.
Canonical URL: https://wefunder.com/smartweave.inc
Updated at: 2026-06-07T23:54:19Z

Tagline: Personalized connective tissue treatments. For patients who deserve better than one-size-fits-all.  
Elevator pitch: Smartweave is transforming surgical implants by leveraging AI-driven design, 3D bioprinting and biomaterials science in a tightly orchestrated symphony of innovation. Initially, we are focused on mesh sling implants used to surgically treat urinary incontinence -- a condition from which millions suffer. Later we'll evolve our proprietary smart tissue technology so to expand into multi-B$ adjacent markets, such as colorectal surgery, orthopedics, GI tract injuries and wound care.

Key claims:
- Total raised on Wefunder: 176956 | citation: https://wefunder.com/smartweave.inc#claim-total-raised
- Total investors: 30 | citation: https://wefunder.com/smartweave.inc#claim-total-investors

Verified facts:
- Total raised on Wefunder: 176956 | observed_at: 2026-06-07T23:54:19Z | expires_at: 2026-06-08T23:54:19Z
- Total investors: 30 | observed_at: 2026-06-07T23:54:19Z | expires_at: 2026-06-08T23:54:19Z

Computed metrics:
- total_amount_raised: 176956
- total_investors: 30
- team_size: 10
- featured_investor_count: 1
- faq_count: 3
- recent_post_count: 1

Quick facts:
- One of fifteen startups that were selected by Swiss EPFL affiliated Tech4Eva from 300+ ventures | citation: https://wefunder.com/smartweave.inc#claim-fact-1
- $6.4M in grants and institutional support secured before opening raise | citation: https://wefunder.com/smartweave.inc#claim-fact-2
- Key collaborators secured $12M+ to move enabling R&D toward pre-IND stage. | citation: https://wefunder.com/smartweave.inc#claim-fact-3
- Lab-validated technology shown to reduce inflammation, repair tendons, and restore continence. | citation: https://wefunder.com/smartweave.inc#claim-fact-4
- 150+ years of combined expertise from top institutions in therapeutics, devices, and R&D. | citation: https://wefunder.com/smartweave.inc#claim-fact-5
- Generated $3.5M from IP in 2 years, with product and licensing revenue growing. | citation: https://wefunder.com/smartweave.inc#claim-fact-6
- Multiple US patents secured, growing to 50+ across AI, scaffolds, and 3D printing. | citation: https://wefunder.com/smartweave.inc#claim-fact-7
- $100B+ connective tissue restoration market projected by 2030. | citation: https://wefunder.com/smartweave.inc#claim-fact-8

FAQ:
- Q: Hi, You say you are "developing an extensive, world-class patent portfolio". Can you update us on the status of your IP Portfolio?
  A: Hi Kim Thanks for reaching out and for your interest in Smartweave. Our team brings 100+ years of experience growing world-class, IP-centric enterprises. As such, we brought this expertise to bear to build Smartweave’s IP portfolio. Today, the portfolio comprises multiple issued seminal patents (which are being cited by other patent families held by key industry leaders), trade secrets, and applications covering key therapeutic formulations, bio-coatings, bio-mechanical, bio-sensing, and AI-e...
- Q: Super interesting. What is the nature of the $3.5M of intangible assets or IP contributed to the company, and did these assets generate the $1.6M in licensing revenues? How was this IP acquired originally? Who contributed the $350k loan and is this convertible into equity or m...
  A: Thanks so much for your interest. Somehow your question didn’t appear properly on our end until a recent refresh with our support team at WeFunder. We’d love to engage further with regard to your interest and are happy to organize a call with you at times you offer. Meanwhile, in response to your insightful query — the $3.55M of IP was contributed as patents that had been secured by the Founder. These patents were then licensed to generate the $1.6M in licensing revenue that you noted. The Fo...
- Q: What is the exit plan (acquisition, IPO, merger, etc.) in which investors will be able to see a ROI?
  A: Thank you for your question! We’re building Smartweave with the goal of creating a high-value strategic platform in personalized implants and regenerative therapeutics, seeking to maximize the company's valuation at exit by achieving strategic milestones. While no exit is guaranteed, we believe the most realistic long-term paths are acquisition by a strategic healthcare company, licensing and partnership transactions around our IP and programs, or another broader strategic liquidity event as ...

Recent posts:
- 🚨 Exciting news: Smartweave has officially begun building its own R&D lab in Puerto Rico. (2026-01-28T21:29:44Z) https://wefunder.com/feed/250038